Loading this company
Waters Corporation
WATPrices in USD
TickerWorth ScoreD45/100
What we think
Priced above our range of $155.75 to $294.83.
Price
$434.27USD down −$2.68 (−0.61%)
Close of · Prices are delayed.
This price comes from our backup market-data feed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
$155.75–$294.83
What the price needs: revenue growth of more than 25%/yr for 5 years (our model assumes 16.6%), or investors accepting a ~6.4% discount rate, vs the 10.3% our model uses.
Led by discounted cash flow (DCF) · Steady cash-flow business
Price $442.83Priced · Prices are delayed.
Is it a good business?
- Valuation33 out of 100
- Growth100 out of 100
- Financial health67 out of 100
- Past performance67 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$464.30 across 23 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. It operates in the Diagnostics & Research industry (Healthcare sector), headquartered in United States. The company employs roughly 16,000 people.
Revenue: Waters Instrument Systems 35% · Waters Service 34% · Chemistry Consumables 20% · Ta Instrument Systems 8% · 1 more
Key stats
52-week range$282.77–$454.54
- Open
- $436.55
- Day high
- $441.28
- Day low
- $433.27
- Previous close
- $436.95
- Volume
- 468,722 · 0.58× avg
- Average volume
- 813,209
- Market cap
- $42,639,171,584.00
- P/E (TTM)
- 110.50
- Earnings per share
- $3.93
- Beta
- 1.15
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Changed leadership or its board
- Reported quarterly or annual results
- Reported shareholder vote results
- Reported quarterly or annual results
- Signed a material agreement
- Disclosed another material event
- Completed an acquisition or sale of assets
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Knight HeatherGrant / award · —
- Jiang WeiGrant / award · —
- KUEBLER CHRISTOPHER A
Not investment advice. TickerWorth Score is a model output.